Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market
Summary
GBI Research, the leading business intelligence provider, has released its latest research: “Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market”, which provides in-depth analysis of the critical care market in the US, UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an estimation of market size for 2013, along with market forecasts to 2020. It covers critical care indications that are being treated using the five major plasma-derived products of albumin, anti-thrombin concentrates, factor XIII concentrates, fibrinogen concentrates, and prothrombin complex concentrates.
The total value of the critical care market in the major developed markets was estimated at $1.8 billion in 2013 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 4.7% to $2.5 billion in 2019. This growth is attributed to the recent approval of new factor concentrates in the US that are expected to witness increasing uptake in the forecast period. Factor concentrates are increasingly preferred due to their lower infection risks over older alternatives such as FFP and cryoprecipitate in critical care settings.
The US accounts for the largest share (41%) of the global critical care market and is expected to post high growth at a CAGR of 7.5% until 2020. KCentra, the first four-factor PCC in the US, and Tretten, the first recombinant FXIII concentrate, were approved in 2013 and are expected to witness good uptake in the forecast period. Two additional factor concentrates approved in the US in 2009 - RiaStap (human fibrinogen concentrate) and ATryn (recombinant AT concentrate) - are also expected to increase their uptake, which will contribute to market growth. With no new significant launches in the forecast period, the European market is estimated to witness much slower growth, with the UK at a CAGR of 3.0%, France at 2.5%, Germany and Spain both at 2.3%, and Italy at 2.0%
Scope
The report analyzes treatment usage patterns, market characterization, pipeline analysis and key licensing and co-development deals in critical care in the eight major developed markets of the US, UK, France, Germany, Italy, Spain, Japan and Canada.The report includes -
- A brief introduction to the five major plasma-derived products in critical care and the indications that they are being used to treat, as well as disease overview, epidemiology, other treatment options, and treatment patterns
- Analysis of major marketed products in critical care, covering product performance in terms of the safety and efficacy of recent approvals
- A review of the critical care pipeline, including individual analysis of promising late-stage pipeline drugs that are most likely to enter the market during the forecast period
- Multi-scenario forecasts of the critical care market over the 2013–2020 period in the eight major developed markets
- Key drivers and restraints that have had and are expected to have a significant impact on the market
- An overview of major licensing and co-development agreements that could affect growth trends
Reasons to buy
The report will enhance your decision-making capability by allowing you to -
- Align your product portfolio to markets with high growth potential
- Develop market entry and expansion strategies by identifying the regions and therapeutic segments poised for strong growth
- Devise effective, tailored strategies for each country through the understanding of key drivers and barriers in the critical care drugs market
- Develop key strategic initiatives based on an understanding of key focus areas and leading companies
- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships
1 Table of Contents
1 Table of Contents 7
1.1 List of Tables 9
1.2 List of Figures 10
2 Introduction 11
3 Respiratory Diseases – Overview 12
3.1 Chronic Obstructive Pulmonary Disease – Epidemiology 12
4 Global Ventilators Market: Definitions 13
4.1 Adult/Pediatric Ventilators 13
4.2 Neonatal Ventilators 13
4.2.1 Transport Ventilators 13
5 Global Ventilators Market: Market Characterization 14
5.1 Global Ventilators Market, Revenue, 2006–2020 14
5.2 Ventilators Market, Global, Key Company Shares, 2013 15
5.3 Ventilators Market, Key Trends 16
5.3.1 Companies Focus on Development of Multimodal Ventilators to Prevent Lung Injury and Asynchrony 16
5.3.2 Advancements in Software, Facial Masks and Home Ventilation to Drive Growth of Ventilators 18
5.4 Market Dynamics 18
5.4.1 Market Drivers 19
5.4.2 Market Restraints 22
6 Global Ventilators Market: Country Analysis and Forecasts 24
6.1 Ventilators Market: Cross-country Analysis 24
6.2 Historic and Forecast Revenue and Volume, by Country 25
6.2.1 Ventilators Market, US, Revenue and Volume, 2006–2020 25
6.2.2 Ventilators Market, Japan, Revenue and Volume, 2006–2020 28
6.2.3 Ventilators Market, Germany, Revenue and Volume, 2006–2020 30
6.2.4 Ventilators Market, France, Revenue and Volume, 2006–2020 33
6.2.5 Ventilators Market, UK, Revenue and Volume, 2006–2020 36
6.2.6 Ventilators Market, Spain, Revenue and Volume, 2006–2020 39
6.2.7 Ventilators Market, Italy, Revenue and Volume, 2006–2020 42
6.2.8 Ventilators Market, Canada, Revenue and Volume, 2006–2020 44
6.2.9 Ventilators Market, China, Revenue and Volume, 2006–2020 46
6.2.10 Ventilators Market, Australia, Revenue and Volume, 2006–2020 48
6.2.11 Ventilators Market, India, Revenue and Volume 2006–2020 51
6.2.12 Ventilators Market, Brazil, Revenue and Volume, 2006–2020 54
7 Global Ventilators Market: Reimbursement System 57
7.1 US 57
7.2 Europe 57
7.2.1 Germany 57
7.2.2 France 57
7.2.3 Spain 58
7.2.4 UK 58
8 Global Ventilators Market: Competitive Landscape 59
8.1 Comparison of Leading Adult, Pediatric and Neonatal Ventilators, 2014 59
8.2 Company Profiles 60
8.2.1 ResMed 60
8.2.2 Philips Respironics (Subsidiary of Koninklijke Philips) 60
8.2.3 Covidien 61
8.2.4 Draegerwerk 61
8.2.5 GE Healthcare (Subsidiary of General Electric) 62
8.2.6 CareFusion 62
8.2.7 Smiths Medical 63
8.2.8 Maquet 63
8.2.9 Hamilton 64
8.2.10 Air Liquide 64
9 Global Ventilators Market: Product Pipeline Analysis 65
9.1 Ventilators Market: List of Pipeline Products 65
9.2 Ventilators Market: Profiles of Key Pipeline Products 65
9.2.1 Astral 65
9.2.2 HiFLO2 Responz 65
9.2.3 Mechanical Ventilator 66
9.2.4 OneBreath Ventilator 66
9.2.5 Portable Ventilator 66
9.2.6 Ventilation Device 67
9.2.7 Ventilator – Neonates 67
9.2.8 Ventilator FRC 67
9.2.9 Ventilator FRC – Home Ventilation 68
9.2.10 WynVent 68
10 Global Ventilators Market: Consolidation Landscape 69
10.1 Key Deals, 2009–2014 69
10.1.1 Medtronic to Acquire Covidien for $42.9 Billion 69
10.1.2 CareFusion’s Acquisition of Intermed Equipamento Medico Hospitalar, Respiratory Device Company 69
11 Appendix 70
11.1 Abbreviations 70
11.2 Bibliography 71
11.3 Research Methodology 72
11.3.1 Secondary Research 72
11.3.2 Primary Research 73
11.3.3 Models 73
11.3.4 Forecasts 73
11.3.5 Expert Panel 74
11.4 Contact Us 74
11.5 Disclaimer 74
List Of Table
1.1 List of Tables
Table 1: Ventilators Market, Global, Chronic Obstructive Pulmonary Disease National Prevalence (%) and Patient Population (million), 2014 12
Table 2: Ventilators Market, Global, Revenue ($m) and Compound Annual Growth Rate (%), 2006–2020 14
Table 3: Ventilators Market, Global, Key Company Share by Region (%), 2013 16
Table 4: Ventilators Market, Examples of Ventilators with Adaptive Pressure Control Mode, 2014 17
Table 5: Ventilators Market, Global, Number of ICU Beds in Key Countries, 2014 20
Table 6: Mechanical Ventilators Market, China, Number of Hospitals, 2004–2013 21
Table 7: Ventilators Market, Global, Cross-country Analysis, 2006–2020 24
Table 8: Ventilators Market, US, Revenue ($m), Volume (‘000) and Compound Annual Growth Rate (%), 2006–2020 27
Table 9: Ventilators Market, Japan, Revenue ($m), Volume (‘000) and Compound Annual Growth Rate (%), 2006–2020 29
Table 10: Ventilators Market, Germany, Revenue ($m), Volume (‘000) and Compound Annual Growth Rate (%), 2006–2020 32
Table 11: Ventilators Market, France, Revenue ($m), Volume (Units) and Compound Annual Growth Rate (%), 2006–2020 35
Table 12: Ventilators Market, UK, Revenue ($m), Volume (Units) and Compound Annual Growth Rate (%), 2006–2020 38
Table 13: Ventilators Market, Spain, Revenue ($m) and Volume (Units), 2006–2020 41
Table 14: Ventilators Market, Italy, Revenue ($m), Volume (Units) and Compound Annual Growth Rate (%), 2006–2020 44
Table 15: Ventilators Market, Canada, Revenue ($m), Volume (Units) and Compound Annual Growth Rate (%), 2006–2020 46
Table 16: Ventilators Market, China, Revenue ($m), Volume (‘000) and Compound Annual Growth Rate (%), 2006–2020 48
Table 17: Ventilators Market, Australia, Revenue ($m), Volume (Units) and Compound Annual Growth Rate (%), 2006–2020 50
Table 18: Ventilators Market, India, Revenue ($m), Volume (‘000) and Compound Annual Growth Rate (%), 2006–2020 53
Table 19: Ventilators Market, Brazil, Revenue ($m), Volume (‘000) and Compound Annual Growth Rate (%), 2006–2020 56
Table 20: ResMed, Key Marketed Products, 2014 60
Table 21: Philips Respironics, Key Marketed Products, 2014 60
Table 22: Covidien, Key Marketed Products, 2014 61
Table 23: Draegerwerk, Key Marketed Products, 2014 61
Table 24: GE Healthcare, Key Marketed Products, 2014 62
Table 25: CareFusion, Key Marketed Products, 2014 62
Table 26: Smiths Medical, Key Marketed Products, 2014 63
Table 27: Maquet, Key Marketed Products, 2014 63
Table 28: Hamilton, Key Marketed Products, 2014 64
Table 29: Air Liquide, Key Marketed Products, 2014 64
Table 30: Ventilators Market, Global, List of Pipeline Products, 2014 65
Table 31: Astral, Product Status, 2014 65
Table 32: HiFLO2 Responz, Product Status, 2014 66
Table 33: Mechanical Ventilator, Product Status, 2014 66
Table 34: OneBreath Ventilator, Product Status, 2014 66
Table 35: Portable Ventilator, Product Status, 2014 67
Table 36: Ventilation Device, Product Status, 2014 67
Table 37: Ventilator – Neonates, Product Status, 2014 67
Table 38: Ventilator FRC, Product Status, 2014 68
Table 39: Ventilator FRC – Home Ventilation, Product Status, 2014 68
Table 40: WynVent, Product Status, 2014 68
List Of Figures
1.2 List of Figures
Figure 1: Ventilators Market, Device Overview 13
Figure 2: Ventilators Market, Global, Revenue ($m), 2006–2020 14
Figure 3: Ventilators Market, Global, Key Company Share by Region (%), 2013 15
Figure 4: Ventilators Market, Market Dynamics 18
Figure 5: Ventilators Market, Comparison of Invasive and Non-invasive Ventilation, 2014 19
Figure 6: Mechanical Ventilators Market, China, Number of Hospitals (‘000), 2004–2013 21
Figure 7: Ventilators Market, Global, Cross-country Analysis, Compound Annual Growth Rate (%), 2006–2020 24
Figure 8: Ventilators Market, US, Cross-segment Analysis, Compound Annual Growth Rate (%), 2006–2020 25
Figure 9: Ventilators Market, US, Revenue ($m) and Volume (‘000), 2006–2020 26
Figure 10: Ventilators Market, Japan, Cross-segment Analysis, Compound Annual Growth Rate (%), 2006–2020 28
Figure 11: Ventilators Market, Japan, Revenue ($m) and Volume (‘000), 2006–2020 28
Figure 12: Ventilators Market, Germany, Cross-segment Analysis, Compound Annual Growth Rate (%), 2006–2020 30
Figure 13: Ventilators Market, Germany, Revenue ($m) and Volume (‘000), 2006–2020 31
Figure 14: Ventilators Market, France, Cross-segment Analysis, Compound Annual Growth Rate (%), 2006–2020 33
Figure 15: Ventilators Market, France, Revenue ($m) and Volume (Units), 2006–2020 34
Figure 16: Ventilators Market, UK, Cross-segment Analysis, Compound Annual Growth Rate (%), 2006–2020 36
Figure 17: Ventilators Market, UK, Revenue ($m) and Volume (Units), 2006–2020 37
Figure 18: Ventilators Market, Spain, Cross-segment Analysis, Compound Annual Growth Rate (%), 2006–2020 39
Figure 19: Ventilators Market, Spain, Revenue ($m) and Volume (Units), 2006–2020 40
Figure 20: Ventilators Market, Italy, Cross-segment Analysis, Compound Annual Growth Rate (%), 2006–2020 42
Figure 21: Ventilators Market, Italy, Revenue ($m) and Volume (Units), 2006–2020 43
Figure 22: Ventilators Market, Canada, Cross-segment Analysis, Compound Annual Growth Rate (%), 2006–2020 44
Figure 23: Ventilators Market, Canada, Revenue ($m) and Volume (Units), 2006–2020 45
Figure 24: Ventilators Market, China, Cross-segment Analysis, Compound Annual Growth Rate (%), 2006–2020 46
Figure 25: Ventilators Market, China, Revenue ($m) and Volume (‘000), 2006–2020 47
Figure 26: Ventilators Market, Australia, Cross-segment Analysis, Compound Annual Growth Rate (%), 2006–2020 48
Figure 27: Ventilators Market, Australia, Revenue ($m) and Volume (Units), 2006–2020 49
Figure 28: Ventilators Market, India, Cross-segment Analysis, Compound Annual Growth Rate (%), 2006–2020 51
Figure 29: Ventilators Market, India, Revenue ($m) and Volume (‘000), 2006–2020 52
Figure 30: Ventilators Market, Brazil, Cross-segment Analysis, Compound Annual Growth Rate (%), 2006–2020 54
Figure 31: Ventilators Market, Brazil, Revenue ($m) and Volume (‘000), 2006–2020 55
Figure 32: Ventilators Market, Comparison of Leading Adult, Pediatric and Neonatal Ventilators, 2014 59
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : December 2019
$ 3600
Published On : November 2019
$ 3600
Published On : October 2019
$ 2950
Published On : October 2019
$ 2950
Published On : October 2019
$ 2950
